Nemaura Medical Inc.
NMRD
$0.0002
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -100.00% | -98.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -100.00% | -98.37% |
| Cost of Revenue | -- | -- | -- | 759.86% | -98.26% |
| Gross Profit | -- | -- | -- | -1,096.02% | -100.00% |
| SG&A Expenses | 1.62% | 13.84% | 19.03% | -37.14% | -11.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.26% | 20.72% | 28.85% | 19.68% | -17.67% |
| Operating Income | 5.09% | -26.22% | -28.85% | -35.38% | 9.40% |
| Income Before Tax | -25.94% | 68.79% | 33.06% | -18.03% | 49.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.94% | 68.79% | 33.06% | -29.46% | 49.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.94% | 68.79% | 33.06% | -29.46% | 49.99% |
| EBIT | 5.09% | -26.22% | -28.85% | -35.38% | 9.40% |
| EBITDA | 4.39% | -23.78% | -30.80% | -33.10% | 11.90% |
| EPS Basic | -5.06% | 74.00% | 44.14% | -13.22% | 51.63% |
| Normalized Basic EPS | -4.94% | 74.00% | 44.15% | 18.33% | 51.63% |
| EPS Diluted | -5.06% | 68.75% | 44.14% | -13.22% | 51.63% |
| Normalized Diluted EPS | -4.94% | 74.00% | 44.15% | 18.33% | 51.63% |
| Average Basic Shares Outstanding | 19.90% | 19.90% | 19.90% | 14.29% | 3.39% |
| Average Diluted Shares Outstanding | 19.90% | 19.90% | 19.90% | 14.29% | 3.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |